Precigen

(NASDAQ) PGEN

Current Price$4.15

Market Cap$1.46B

Since IPO (2013)-83%

5 Year-47%

1 Year+168%

1 Month+27%

Precigen Financials at a Glance

Market Cap

$1.46B

Revenue (TTM)

$9.68M

Net Income (TTM)

$250.64M

EPS (TTM)

$-1.40

P/E Ratio

-2.94

Dividend

$0.00

Beta (Volatility)

1.76 (High)

Dividend

$0.00

Beta (Volatility)

1.76 (High)

Price

$4.15

Volume

17,693

Open

$4.09

Price

$4.15

Volume

17,693

Open

$4.09

Previous Close

$4.12

Daily Range

$4.09 - $4.18

52-Week Range

$1.23 - $5.46

Dividend

$0.00

Beta (Volatility)

1.76 (High)

Price

$4.15

Volume

17,693

Open

$4.09

Previous Close

$4.12

Daily Range

$4.09 - $4.18

52-Week Range

$1.23 - $5.46

PGEN News

Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?

Jonathan PoncianoDec 2, 2025

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

Cory RenauerNov 1, 2025

investors-picking-stocks-on-computer-getty

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

Cory RenauerSep 7, 2025

investor ponders phone and laptop stock charts

2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years

Alex CarchidiMar 17, 2023

Page 1

PGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precigen

Industry

Biotechnology

Sector

Health Care

Employees

160

CEO

Helen Sabzevari, PhD

Website

www.precigen.com

Headquarters

Germantown, MD 20876, US

PGEN Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-11%

Net Income Margin

-26%

Return on Equity

-572%

Return on Capital

-93%

Return on Assets

-2%

Earnings Yield

-34.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.46B

Shares Outstanding

353.93M

Volume

17.69K

Avg. Volume

4.52M

Financials (TTM)

Gross Profit

$3.59M

Operating Income

$106.60M

EBITDA

$103.40M

Operating Cash Flow

$87.83M

Capital Expenditure

$2.00M

Free Cash Flow

$89.83M

Cash & ST Invst.

$97.86M

Total Debt

$5.12M

Precigen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$4.57M

+283.6%

Gross Profit

$2.65M

+12523.8%

Gross Margin

58.07%

N/A

Market Cap

$1.46B

N/A

Market Cap/Employee

$10.20M

N/A

Employees

143

N/A

Net Income

$23.50M

-19.1%

EBITDA

$20.53M

-7.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$92.74M

+0.4%

Accounts Receivable

$4.36M

+275.1%

Inventory

$9.58M

N/A

Long Term Debt

$3.98M

-12.5%

Short Term Debt

$1.14M

+18.8%

Return on Assets

-1.60%

N/A

Return on Invested Capital

-92.62%

N/A

Free Cash Flow

$24.08M

-159.8%

Operating Cash Flow

$23.46M

-184.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMTXImmatics N.V.

IMTXImmatics N.V.$11.33+1.16%

WVEWave Life Sciences Ltd.

WVEWave Life Sciences Ltd.$7.01-0.50%

AMLXAmylyx Pharmaceuticals, Inc.

AMLXAmylyx Pharmaceuticals, Inc.$15.57-0.17%

TRMLTourmaline Bio, Inc.

TRMLTourmaline Bio, Inc.$47.98+0.00%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$83.75+0.66%

ORICORIC Pharmaceuticals, Inc.

ORICORIC Pharmaceuticals, Inc.$9.61+1.80%

RLAYRelay Therapeutics, Inc.

RLAYRelay Therapeutics, Inc.$12.75+1.47%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.25-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.79+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.72-0.02%

HTZHertz Global

HTZHertz Global$6.95+0.24%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.55+0.08%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.14-0.08%

WULFTeraWulf

WULFTeraWulf$21.36+0.07%

Questions About PGEN

What is the current price of Precigen?

Precigen is trading at $4.15 per share.

What is the 52-week range for Precigen?

Over the past 52 weeks, Precigen has traded between $1.23 and $5.47.

How much debt does Precigen have?

As of the most recent reporting period, Precigen reported total debt of $98.29M.

How much cash does Precigen have on hand?

Precigen reported $30.23M in cash and cash equivalents in its most recent financial results.

What is Precigen’s dividend yield?

Precigen does not currently have a dividend yield.

Precigen

Precigen Financials at a Glance

PGEN News

Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet?

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years

Why Precigen Stock Is Skyrocketing Today

Here's Why Intrexon Jumped 58% in June

Why Intrexon Stock Popped Today

Why Intrexon Stock Dropped 34% in March

PGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Precigen

PGEN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Precigen Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PGEN

What is the current price of Precigen?

What is the 52-week range for Precigen?

How much debt does Precigen have?

How much cash does Precigen have on hand?

What is Precigen’s dividend yield?

Premium Investing Services